Lukas Joos
0000-0001-6175-5966
1 paper found
Refreshing results…
Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study
Missing publications? Search for publications with a matching author name.